SCHEMBL26833451

SCHEMBL26833451

c1ccc2cc(-c3ccc4c(ccc5cc(N(c6ccc(-c7ccc8ncccc8c7)cc6)c6ccc(-c7cnc8ccccc8c7)cc6)ccc54)c3)ccc2c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 1/20 0.50
▸ POLB P06746 1/20 0.50
▸ RAB9A P51151 1/20 0.50
▸ PDGFRB P09619 2/20 0.48
▸ PDGFRA P16234 2/20 0.48
▸ PIK3CD O00329 3/20 0.47
▸ PIK3CA P42336 3/20 0.47
▸ CYP2A6 P11509 1/20 0.46
▸ MTOR P42345 3/20 0.44
▸ PIK3CB P42338 2/20 0.44
▸ PIK3CG P48736 2/20 0.44
▸ DYRK1A Q13627 1/20 0.43
▸ CA12 O43570 1/20 0.42
▸ CA1 P00915 1/20 0.42
▸ CA2 P00918 1/20 0.42
▸ CA9 Q16790 1/20 0.42
▸ BIRC5 O15392 1/20 0.42
▸ MCL1 Q07820 1/20 0.41
▸ NISCH Q9Y2I1 1/20 0.40
▸ CYP17A1 P05093 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26833504 0.94 PDGFRB (0.44) NPC1POLBRAB9APDGFRBPDGFRA
SCHEMBL26833448 0.94 PDGFRB (0.50) NPC1POLBRAB9APDGFRBPDGFRA
SCHEMBL26834584 0.94 NPC1 (0.57) NPC1POLBRAB9APDGFRBPDGFRA
SCHEMBL26834053 0.89 NPC1 (0.57) NPC1POLBRAB9APIK3CDPIK3CA
SCHEMBL26834052 0.89 PIK3CD (0.52) PDGFRBPDGFRAPIK3CDPIK3CACYP2A6
SCHEMBL26833668 0.89 LMNA (0.44) NPC1POLBRAB9APDGFRBPDGFRA
SCHEMBL26833457 0.88 NPC1 (0.47) NPC1POLBRAB9ADYRK1AMCL1
SCHEMBL26833512 0.87 PDGFRB (0.50) PDGFRBPDGFRAPIK3CDPIK3CACYP2A6
SCHEMBL26833586 0.87 MAPK10 (0.46) NPC1RAB9APDGFRBPDGFRAPIK3CD
SCHEMBL26833526 0.87 CYP19A1 (0.40) NPC1POLBRAB9APDGFRBPDGFRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230357188-A1 PHENANTHRENE ORGANIC COMPOUND AND USE THEREOF WUHAN TIANMA MICROELECTRONICS CO., LTD. (CN) 2023-11-09 — — US disclosed
US-20230357188-A1 PHENANTHRENE ORGANIC COMPOUND AND USE THEREOF WUHAN TIANMA MICROELECTRONICS CO., LTD. (CN) 2023-11-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230357188-A1 PHENANTHRENE ORGANIC COMPOUND AND USE THEREOF AHR, ORAI3, WNT3 NPC1 2396/4885POLB 2432/4885RAB9A 3127/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback